Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases

43Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Extracellular vesicles are heterogeneous populations of naturally occurring secreted small vesicles. EVs function as signaling platforms to facilitate intracellular communication, which indicates the physiological or pathophysiological conditions of cells or tissues. Considering that EVs can be isolated from most body fluids and that molecular constituents could be reprogrammed according to the physiological status of the secreting cells, EVs are regarded as novel diagnostic and prognostic biomarkers for many diseases. The ability to protect encapsulated molecules from degradation in body fluids suggests the potential of EVs as biological medicines or drug delivery systems. This article focuses on the EV-associated biomarkers and therapeutic approaches in autoimmune diseases.

Cite

CITATION STYLE

APA

Xu, K., Liu, Q., Wu, K., Liu, L., Zhao, M., Yang, H., … Wang, W. (2020, December 1). Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases. Journal of Translational Medicine. BioMed Central Ltd. https://doi.org/10.1186/s12967-020-02609-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free